Exdensur
Customize your policy alerts
Sign up for Cigna Policy IP0787 alerts
Get alerted when Policy IP0787 changes without checking for updates manually.
Monitor payer policy activity
Prior authorization and benefit coverage for Exdensur (depemokimab-ulaa) subcutaneous injection in adults and pediatric patients aged 12 years and older with severe eosinophilic asthma, subject to clinical, specialist, preferred-product, continuation, dosing, and coding criteria.
HCPCS code J2361 for injection of depemokimab-ulaa, 1 mg, was added to the coding information.
Descriptions for HCPCS codes C9399, J3490, and J3590 were updated in the coding information.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.